Earnings Call · Q1 FY2022·2022-05-09

Q1 22EPS -16.15%·Rev n/aQ4 21EPS -21.50%·Rev n/aQ3 21EPS -7.53%·Rev n/aQ2 21EPS -30.43%·Rev n/a⚠ consensus missing

Praxis Precision Medicines, Inc. PRAX

Alex Kane — Investor Relations or Corporate Communications (inferred from hosting the call)

+24.6%1d on move date+24.4% vs SPY3d+22.7%5d+47.8%

Research tier

Behavioral profile computed for this call's speaker on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more PRAX calls or request research access.

More PRAX calls Browse calls Request research access